Severin Schwan

Chief Executive Officer, Roche Group

Personalized Healthcare: Getting from Promise to Reality

On Thursday, December 2 at the Chief Executives’ Club of Boston, Severin Schwan, chief executive officer of the Roche Group, spoke about challenges in the healthcare industry and creating personalized healthcare solutions by combining pharmaceuticals with diagnostic technology. Martin Madaus, president and chief executive officer of Millipore Corporation, introduced Schwan.

TAKEAWAYS

“No country spends more on healthcare than the U.S. … and all the analysts agree that this … will go up as we go forward.” READ TRANSCRIPT AND VIEW VIDEO »

“So-called Phase 1 trials [on patients with malignant melanoma] … have been completed, and, literally, the tumors are melting away.” READ TRANSCRIPT AND VIEW VIDEO »

“If … a company … just patents thousands of genes, and then [asks] anybody who works with those genes for royalties or access rights … that would slow down progress in science.” READ TRANSCRIPT AND VIEW VIDEO »

“[In the next 10 years, pharmaceutical companies that have] neither a rock-bottom cost structure [nor] little differentiation with … research and development … will be squeezed out.” READ TRANSCRIPT AND VIEW VIDEO »

PRESS COVERAGE

Reuters: “Roche CEO sees generic co’s, innovators as winners” READ ARTICLE »

Boston Globe: “Roche CEO predicts rapid consolidation: Focus will be on biotech, he says” 
READ ARTICLE »

Boston Herald: “Roche chief touts skin-cancer drug” 
READ ARTICLE »

New England Cable News: “Severin Schwan, CEO, Roche Group” VIEW VIDEO »

EVENT PHOTOS